The aim of this project is the interdisciplinary study of viral-induced demyelination and persistance. The project will concentrate on host factors in JHM virus infection. JHM is a mouse coronavirus which serves as a useful model to study the many factors by which a virus could play a role in the pathogenesis of multiple sclerosis. JHM produces a persistent infection and chronic demyelination. The genetic background of the host appears to play an important role in susceptibility and the model can be used both in vivo and in vitro to study basic questions of viral-cell interactions in regard to the immune system and the role of specific CNS cells in the establishment and maintenance of chronic infections. Host factors will be studied by (1) defining the genetic influences such as the identification of specific genes and their linkage relationships to known markers which might give a clue to the mechanism of their action, (2) characterizing antiviral antibody, proliferative and cytotoxic T cell responses by using virus-specific T cell clones and by defining the role of NK cells in a chronic process where the virus does not elicit interferon production, (3) utilizing monoclonal antiviral antibody to study antibody-viral interactions at the cell serface with specific reference to the establishment and maintenance of persistent infection, the induction and mechanism of antigenic drift and alterations in the selective vulnerability of CNS celss to chronic infection. The JHM virus-cell interactions will be studied in vivo and in vitro utilizing animals of specific genetic background and extensive tissue culture systems. Genetics, immunologic, virologic, and neurobiologic techniques will be employed in an extensive collaborative effort.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Program Projects (P01)
Project #
5P01NS018146-05
Application #
3099713
Study Section
Neurological Disorders Program Project Review B Committee (NSPB)
Project Start
1982-04-01
Project End
1990-03-31
Budget Start
1986-04-01
Budget End
1987-03-31
Support Year
5
Fiscal Year
1986
Total Cost
Indirect Cost
Name
University of Southern California
Department
Type
Schools of Medicine
DUNS #
041544081
City
Los Angeles
State
CA
Country
United States
Zip Code
90033
Kapil, Parul; Butchi, Niranjan B; Stohlman, Stephen A et al. (2012) Oligodendroglia are limited in type I interferon induction and responsiveness in vivo. Glia 60:1555-66
Savarin, Carine; Stohlman, Stephen A; Rietsch, Anna M et al. (2011) MMP9 deficiency does not decrease blood-brain barrier disruption, but increases astrocyte MMP3 expression during viral encephalomyelitis. Glia 59:1770-81
Savarin, Carine; Stohlman, Stephen A; Atkinson, Roscoe et al. (2010) Monocytes regulate T cell migration through the glia limitans during acute viral encephalitis. J Virol 84:4878-88
Phares, Timothy W; Stohlman, Stephen A; Hinton, David R et al. (2010) Enhanced antiviral T cell function in the absence of B7-H1 is insufficient to prevent persistence but exacerbates axonal bystander damage during viral encephalomyelitis. J Immunol 185:5607-18
Phares, Timothy W; Ramakrishna, Chandran; Parra, Gabriel I et al. (2009) Target-dependent B7-H1 regulation contributes to clearance of central nervous system infection and dampens morbidity. J Immunol 182:5430-8
Zuo, Jun; Stohlman, Stephen A; Parra, Gabriel I et al. (2009) IL-15 independent maintenance of virus-specific CD8(+) T cells in the CNS during chronic infection. J Neuroimmunol 207:32-8
Savarin, Carine; Bergmann, Cornelia C (2008) Neuroimmunology of central nervous system viral infections: the cells, molecules and mechanisms involved. Curr Opin Pharmacol 8:472-9
Stohlman, S A; Hinton, D R (2001) Viral induced demyelination. Brain Pathol 11:92-106
Stohlman, S A; Bergmann, C; Cua, D et al. (1994) Location of antibody epitopes within the mouse hepatitis virus nucleocapsid protein. Virology 202:146-53
Strong, R K; Penny, D M; Feldman, R M et al. (1994) Engineering and expression of a secreted murine TCR with reduced N-linked glycosylation. J Immunol 153:4111-21